Contact Us
As human brain organoids and other 3D neural models become increasingly sophisticated, researchers are looking beyond cellular identity and structure to demonstrate whether these models exhibit meaningful physiological function.
This shift is particularly relevant during peer review. While molecular profiling, immunostaining, and imaging can provide important evidence about what cells are present and how they develop, reviewers may also ask for functional evidence that demonstrates what those cells are actually doing.
Moving Beyond Structural Characterization
Brain organoid characterization traditionally relies on methods such as RNA sequencing, immunostaining, and microscopy. These approaches can establish gene expression, cellular identity, and tissue organization.
But identifying neurons does not necessarily demonstrate that those neurons are electrically active.
Electrophysiology data provides a complementary functional readout by directly measuring electrical activity from neurons. Measurements such as action potentials, spike patterns, and local field potentials can provide evidence of neuronal activity that cannot be determined from molecular or structural characterization alone.
For studies focused on neurological disease, development, or therapeutic response, this distinction can be particularly important.
Electrophysiology as Part of Organoid Validation
Organoid validation is ultimately about demonstrating that a model is relevant to the biological question being studied.
For example, researchers may identify a disease-associated molecular phenotype in a brain organoid. A natural next question is whether that phenotype is also associated with changes in neuronal function.
Similarly, when testing a therapeutic intervention, molecular or morphological changes may tell part of the story—but researchers may also want to know whether treatment changes the functional behavior of neurons.
This is where electrophysiological characterization can strengthen the overall evidence package.
Electrophysiology does not replace other characterization methods. Instead, it adds another layer of evidence:
- Molecular data: What genes are being expressed?
- Imaging and histology: What cells and structures are present?
- Electrophysiology: Are the neurons generating electrical activity?
Together, these measurements can provide a more complete picture of a 3D neural model.
Why 3D Makes Functional Measurement More Challenging
Measuring electrophysiology in intact 3D neural models also presents a unique challenge. Many established platforms were designed primarily for 2D cultures, where neurons are positioned close to an accessible measurement surface.
Brain organoids, however, contain neurons distributed throughout a three-dimensional tissue structure. As a result, surface measurements may not capture activity occurring deeper within the model.
For researchers studying intact organoids, accessing neuronal activity at different depths can provide complementary information about physiological function.
Strengthening the Evidence for Neuroscience Publications
Not every neuroscience publication requires electrophysiology. The appropriate methods depend on the scientific question and the claims being made.
However, as researchers make increasingly sophisticated claims about disease phenotypes, therapeutic effects, and functional relevance, demonstrating neuronal activity can provide valuable supporting evidence during peer review.
Molecular data can show what is there. Structural data can show what it looks like. Electrophysiology can help show what it is doing.
For researchers developing human brain organoids for disease modeling, drug discovery, and neuroscience research, incorporating electrophysiology into the characterization workflow can provide an important functional dimension to the model—and a stronger foundation for demonstrating physiological relevance.